Heart Valves Market to Exhibit 11.7% CAGR by 2026; Rising Geriatric Population with Growing Number of Cardiovascular Disorders Will Attract High Revenue: Fortune Business Insights™

Key Companies Covered in the Heart Valves Market Research Report are Abbott, LivaNova PLC, CryoLife Inc., Edward Lifesciences Corporation, Medtronic, Boston Scientific Corporation, Micro Interventional Devices, Inc. and other key market players.


Pune, April 06, 2020 (GLOBE NEWSWIRE) -- The global Heart Valves market size is expected to reach USD 15.98 billion by 2026, on account of the advent of customized Heart Valvess. A Heart Valves allows blood to flow in only one direction through the heart. Blood passes through a valve before leaving every chamber of the heart. These valves helps to abstain the backward flow of blood. A recently published report by Fortune Business Insights™ titled, “Heart Valves Market Size, Share & Industry Analysis, By Product Type (Replacement (Aortic, Mitral, and Others), and Repair), By Valve Type (Tissue Valve and Mechanical Valve), By Procedure (Surgical and Transcatheter), By End User (Hospitals, and Specialty Clinics & Others), and Regional Forecast, 2019-2026” discusses the market and its growth parameters in details. As per this report, the market value was USD 6.58 billion in 2018 and will rise at a CAGR of 11.7% between 2019 and 2026.


For more information in the analysis of this report, visit:
https://www.fortunebusinessinsights.com/industry-reports/heart-valves-market-101183


What is the Scope of the Report?

The report presents a comprehensive overview of the market with its prime growth parameters such as drivers, restraints, challenges, and upcoming opportunities. It discusses the market segmentation and the overall competitive landscape in details. List of players and their key strategies to gain a competitive edge in the market are also discussed in the report. Furthermore, the report provides key industry developments, current Heart Valves market trends, and other interesting insights.

An Overview of the Impact of COVID-19 on this Market:

The emergence of COVID-19 has brought the world to a standstill. We understand that this health crisis has brought an unprecedented impact on businesses across industries. However, this too shall pass. Rising support from governments and several companies can help in the fight against this highly contagious disease. There are some industries that are struggling and some are thriving. Overall, almost every sector is anticipated to be impacted by the pandemic.

We are taking continuous efforts to help your business sustain and grow during COVID-19 pandemics. Based on our experience and expertise, we will offer you an impact analysis of coronavirus outbreak across industries to help you prepare for the future.


To get the short-term and long-term impact of COVID-19 on this Market.
Please visit:
 https://www.fortunebusinessinsights.com/industry-reports/heart-valves-market-101183


Market Drivers


Increasing Popularity of Minimally Invasive Surgeries Will Add Impetus

Rise in sedentary lifestyle, adoption of irregular eating habits and the increasing preference for ready-to-eat food have resulted in a number of cholesterol and obesity cases. This acts as a major Heart Valves market growth factor. Besides this, the rise in geriatric population and their vulnerability to various cardiovascular disorders is also expected to aid in expansion of the market in the forecast period.

However, the complications associated with Heart Valves repair and replacement surgeries may retract many patients from opting for this surgery. This may hamper the overall market growth. Nevertheless, the advent of latest technology, increasing popularity of minimally invasive surgeries, and launch of innovative products are expected to create lucrative growth opportunities for the market in the coming years.


Request a Sample Copy of the Research Report:
https://www.fortunebusinessinsights.com/enquiry/request-sample-pdf/heart-valves-market-101183


Regional Segmentation:


North America Dominating Market with Rising Number of Valve Repair and Replacement Procedures

Based on geographical viewpoint, North America is holding the largest Heart Valves market share with a revenue generation of USD 2.64 billion earned in 2018. Growth of this region is attributed to the rise in obese population and increasing number of valve replacement and repair procedures in the region. As per the American Heart Association, about 90,000 valve substitutes undergo implantation on an annual basis in the U.S. This indicates the rise in demand for prosthetic Heart Valvess in the region.

On the other side, Asia Pacific market will witness significant growth in the years to follow on account of the increasing obese and geriatric population, rising adoption of tissue valves at a rapid pace, and support from the government. Besides this, the market in the Middle East and Africa and Latin America will witness a substantial rise on account of the rising cases of Heart Valvess leakage and improvement in healthcare infrastructure and medical facilities.


Competitive Landscape:


Abbott and Edwards Lifesciences to Dominate Market with Strong Portfolio

As per the competitive landscape of the market is concerned, currently two major companies namely Abbott and Edwards Lifesciences are dominating the market. Among these, Edwards Life Sciences ranks first followed by Abbott. This is owing to their diverse portfolio and the rising demand for SAPIEN valve by Edwards Lifesciences. Other companies operating in the market are focusing on development of new products that will be most suitable for patients. They are acquiring strategies such as mergers and acquisitions, company collaborations, contracts and agreements, and others to attract high Heart Valves market revenue in the forthcoming years.

List of Manufacturers in the Heart Valves Market include:

  • Abbott
  • LivaNova PLC
  • CryoLife Inc.
  • Edward Lifesciences Corporation
  • Medtronic
  • Boston Scientific Corporation
  • Micro Interventional Devices, Inc.
  • Other Players


Major Industry Developments of the Heart Valves Market Include:

May 2017 – Symetis SA was acquired by Boston Scientific Corporation for the expansion of the company’s product portfolio.

September 2019 – The pivotal trial called TRILUMINATE for the evaluation of TriClip was launched by Abbott. TriClip is a transcatheter tricuspid valve repair used in the treatment of tricuspid regurgitation.


Have Any Query? Ask Our Experts:
https://www.fortunebusinessinsights.com/enquiry/speak-to-analyst/heart-valves-market-101183


Detailed Table of Content:

  • Introduction
    • Research Scope
    • Market Segmentation
    • Research Methodology
    • Definitions and Assumptions
  • Executive Summary
  • Market Dynamics
    • Market Drivers
    • Market Restraints
    • Market Opportunities
  • Key Insights
    • Epidemiology of Heart Valve Disease – For Key Countries
    • Reimbursement Scenario For Key Countries
    • Regulatory Scenario For Key Countries
    • Technological Advancement in Heart Valve Market
    • New Product Launches
    • Key Industry Developments - Mergers, Acquisitions, and Partnerships
  • Global Heart Valve Market Analysis, Insights and Forecast, 2015-2026
    • Key Findings / Summary
    • Market Analysis, Insights and Forecast – By Product Type
      • Replacement
        • Aortic
        • Mitral
        • Others
      • Repair
    • Market Analysis, Insights and Forecast – By Valve Type
      • Tissue Valve
      • Mechanical Valve
    • Market Analysis, Insights and Forecast – By Procedure
      • Surgical
      • Transcatheter
    • Market Analysis, Insights and Forecast – By End User
      • Hospitals
      • Specialty Clinics & Others
    • Market Analysis, Insights and Forecast – By Region
      • North America
      • Europe
      • Asia Pacific
      • Latin America
      • Middle East & Africa

TOC Continued….!


Request for Customization:
https://www.fortunebusinessinsights.com/enquiry/customization/heart-valves-market-101183


Have a Look at Related Reports:

Cardiac Pacemakers Market Size, Share and Global Trend By Product (Single Chamber Pacemakers, Dual Chamber Pacemakers, Cardiac Resynchronization Therapy-Pacemakers (CRT-P)), By End User (Hospitals & Clinics, Ambulatory Surgery Centers and Others) & Geography Forecast till 2026

Cardiac Rhythm Management (CRM) Devices Market Size, Share and Global Trend Product By (Cardiac Pacemakers, Defibrillators, Cardiac Resynchronization Therapy Devices) By End User (Hospitals & Clinics, Ambulatory Surgery Centers), and Geography Forecast to 2026

Cardiovascular Devices Market Size, Share and Industry Analysis, By Device Type (Diagnostic and Monitoring Devices, and Therapeutic and Surgical Devices), By Application (Coronary Artery Disease (CAD), Cardiac Arrhythmia, Heart Failure, and Others), By End User (Hospitals, Specialty Clinics, and Others), and Regional Forecast, 2019-2026

Cardiovascular Stents Market Size, Share and Industry Analysis By Product Type (Coronary Stenting, Peripheral Stenting), Stent Type (Drug Eluting Stents (DES), Bioresorbable Stents, Bare Metal Stents & Others), Disease Indication (Venous Disease, Arterial Disease), End User and Regional Forecast, 2018 - 2025

Anticoagulants Market Size, Share & Industry Analysis, By Disease Indication (Pulmonary Embolism (PE), Deep Vein Thrombosis (DVT), Atrial Fibrillation, Heart Attacks, Others), By Route of Administration (Oral, Injectable), By Distribution Channel (Hospitals Pharmacies, Retail Pharmacies, Online Pharmacies, Others) and Regional Forecast, 2019-2026

Implantable Cardioverter Defibrillator Market Size, Share and Industry Analysis By Product Type (Transvenous ICD, Subcutaneous ICD), End User (Hospitals & Clinics, Ambulatory Surgery Centers and Others) & Regional Forecast, 2019 – 2026

Defibrillator Market Size, Share and Industry Analysis By Type (Implantable Cardioverter Defibrillator (ICD), Transvenous ICD, External Defibrillator) By End User(Hospitals & Clinics, Ambulatory, Schools and other Public Places) and Regional Forecast, 2019 - 2026

Biomarkers Market Size, Share & Industry Analysis, By Indication (Oncology, Cardiology, Neurology, and Others), By End User (Pharmaceutical & Biotechnology Companies, Diagnostics & Research Laboratories, Hospitals & Specialty Clinics, and Others), and Regional Forecast, 2019-2026

About Us:

Fortune Business Insights™ offers expert corporate analysis and accurate data, helping organizations of all sizes make timely decisions. We tailor innovative solutions for our clients, assisting them to address challenges distinct to their businesses. Our goal is to empower our clients with holistic market intelligence, giving a granular overview of the market they are operating in.

Our reports contain a unique mix of tangible insights and qualitative analysis to help companies achieve sustainable growth. Our team of experienced analysts and consultants use industry-leading research tools and techniques to compile comprehensive market studies, interspersed with relevant data.

At Fortune Business Insights™ we aim at highlighting the most lucrative growth opportunities for our clients. We, therefore, offer recommendations, making it easier for them to navigate through technological and market-related changes. Our consulting services are designed to help organizations identify hidden opportunities and understand prevailing competitive challenges.

Contact Us:

Fortune Business Insights™ Pvt. Ltd.
308, Supreme Headquarters,
Survey No. 36, Baner,
Pune-Bangalore Highway,
Pune - 411045, Maharashtra, India.
Phone:
US :+1 424 253 0390
UK : +44 2071 939123
APAC : +91 744 740 1245
Email: sales@fortunebusinessinsights.com
Fortune Business Insights™
LinkedIn | Twitter | Blogs

Press Release: https://www.fortunebusinessinsights.com/press-release/heart-valves-market-9704